QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Oppenheimer analyst Leland Gershell initiates coverage on Tectonic Therapeutic (NASDAQ:TECX) with a Outperform rating and an...

Core News & Articles

Truist Securities analyst Danielle Brill initiates coverage on Tectonic Therapeutic (NASDAQ:TECX) with a Buy rating and anno...

Core News & Articles

-SEC Filing

Core News & Articles

Raymond James analyst Michael Freeman reinstates Tectonic Therapeutic (NASDAQ:TECX) with a Outperform and announces $76 pric...

Core News & Articles

Data confirmed TX45's tolerability profile and improvements in left ventricular function and pulmonary hemodynamics in pati...

Core News & Articles

Mizuho analyst Uy Ear maintains Tectonic Therapeutic (NASDAQ:TECX) with a Outperform and raises the price target from $51 to...

Core News & Articles

Tectonic Therapeutic (NASDAQ:TECX) reported quarterly losses of $(0.93) per share which beat the analyst consensus estimate of ...

Core News & Articles

Mizuho analyst Uy Ear initiates coverage on Tectonic Therapeutic (NASDAQ:TECX) with a Outperform rating and announces Price ...

Core News & Articles

WATERTOWN, Mass., April 15, 2025 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (NASDAQ:TECX) ("Tectonic"), a clinical ...

Core News & Articles

Wells Fargo analyst Tiago Fauth maintains Tectonic Therapeutic (NASDAQ:TECX) with a Overweight and lowers the price target f...

Core News & Articles

Tectonic Therapeutic (NASDAQ:TECX) reported quarterly losses of $(0.84) per share which beat the analyst consensus estimate of ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION